Your browser doesn't support javascript.
loading
Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran.
Jafari, Abdosaleh; Tabatabaei Far, Sedighe Sadat; Dehghani, Mehdi; Ravangard, Ramin.
  • Jafari A; Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Tabatabaei Far SS; Student Research Committee, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Dehghani M; Department of Hematology and Medical Oncology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Ravangard R; Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Cancer Control ; 30: 10732748231180679, 2023.
Article en En | MEDLINE | ID: mdl-37314727
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article